Abstract
Eating disorders, such as anorexia and bulimia nervosa, are psychiatric disorders that are likely determined by a complex interaction between genetic variations, developmental processes, and certain life events. Cross-species analysis of traits related to eating disorders may provide a way to functionally and systematically study neurobiological mechanisms underlying these disorders. Interspecies trait genetics may offer opportunities to identify common neurobiological mechanisms underlying eating disorder characteristics relevant to the initiation, progression, and/or maintenance of the disease, such as cognitive rigidity, increased anxiety levels, and behavioral hyperactivity. These can subsequently be tested directly by studying allelic variation in mice and human subjects and by applying methods that can modify gene expression levels in rodent models. Increasing our knowledge about these traits and their underlying neurobiological mechanisms will be relevant to develop new therapies for patients within the heterogeneous eating disorder populations. Novel mouse genetic and phenotyping tools offer a way to study these neurobehavioral traits under controlled environmental and genetic background conditions.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Why Studying Eating Disorder Traits?
The human population with eating disorders is highly diverse revealing many different phenotypes both between and within eating disorders. Anorexia nervosa, for example, is a serious psychiatric disorder characterized by severe and selective restriction of food intake. This eating disorder, with a high prevalence among young adolescent females (15–19 years), results in extreme body weight loss and has a mortality rate of up to 15% (Hoek 2006). Anorexia nervosa patients also show other symptoms that are not observed consistently throughout the anorexia nervosa patient population. For example, behavioral hyperactivity is considered an important phenotype of the disease (Bergh and Sodersten 1996; Brewerton et al. 1995b; Davis et al. 1997; Hebebrand et al. 2003), since it leads to accelerated body weight loss and is observed in a large proportion (40–80%) of the anorexia nervosa population. In addition, a large group of anorexia patients suffers an anxiety disorder that is already present pre-morbidly and that can vary greatly between patients [e.g., a general anxiety disorder, social phobia, or panic disorder (Brewerton et al. 1995a; Bulik et al. 1997; Godart et al. 2002; Toner et al. 1988)]. Furthermore, lifetime compulsion and obsession phenotypes occur in a large sample of the anorexia nervosa population (Halmi et al. 2003). Thus, the expression of an eating disorder is not uniform and is characterized by different phenotypes that are variable within the patient population.
Phenotypic heterogeneity within the eating disorder population complicates identification of disease genes and may also reflect differences in the etiology of these disorders. The current diagnostic criteria are not sensitive enough to differentiate between subgroups of anorexia nervosa patients. Further understanding these differences is highly relevant for finding the disease genes as well as in view of developing effective treatment programs that may be directed toward specific pathophysiological features of the disease. Indeed, current treatment possibilities only cure a small proportion of the eating disorder patients [for review, see (Fairburn and Harrison 2003; Treasure et al. 2010)], and high relapse rates are documented (Herzog et al. 1999; Carter et al. 2004). Furthermore, genetic studies have, thus far, not revealed many replicated candidate genes for neither anorexia nervosa nor bulimia nervosa [for review, see (Hinney et al. 2000; Kas et al. 2003b; Klump and Gobrogge 2005; Mazzeo et al. 2006; Bulik et al. 2007b)], suggesting that either different subgroups within the population may relate to differences in affected genetic pathways or major susceptibility genes have not been found. For those reasons, dissecting phenotypic variation across the patient population and targeting those behavioral deficits that are leading to the initiation, progression, and/or maintenance of the disease would be an alternative strategy in the battle against these dramatic disorders.
2 Eating Disorder Traits
Several studies have focused on the identification of heritable phenotypes that are present in the eating disorder population (Keski-Rahkonen et al. 2005; Bulik et al. 2007a; Mazzeo et al. 2009). Recently, Gottesman and Gould (2003) put forward the psychiatric endophenotype concept to facilitate the identification of genes relevant for neuropsychiatric disorders. Endophenotypes, which are expected to have lower genetic heterogeneity than clinical diagnoses, may represent simpler clues to genetic underpinnings than the disease syndrome itself. Furthermore, endophenotypes may not be specific to one psychiatric disorder but have overarching effects impacting on several different diagnoses. This promotes the view that psychiatric diagnoses can be deconstructed to facilitate more straightforward and successful genetic analysis.
As described earlier in a paper by Bulik et al. (2007a), “an endophenotype may be neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, or neuropsychological in nature. Endophenotypes are heritable, cosegregate with a psychiatric illness in the general population, are state independent, (i.e., manifest in the individual whether illness is active), and are found in nonaffected family members at a higher rate than in the general population. Other enhancements of the definition of endophenotype include being linked to the causal process, involved in plausible biological mechanisms, predictive of the disorder probabilistically, and lying closer to the site of the primary causative agent. The term subphenotype has also been used to identify more homogeneous subgroups of complex syndromes (e.g., early onset depression or BN with self-induced vomiting). Although not as clearly defined as endophenotypes, they are commonly used as a means to reduce the heterogeneity inherent in sampling based on a diagnostic category or syndrome. An example of the hierarchy would be: the phenotype of schizophrenia; the subphenotype of individuals with schizophrenia who report auditory hallucinations; and the endophenotype of P50 event-related potential suppression.” Based on these definitions, Bulik et al. (2007a) have generated an overview on potential traits for eating disorders (Table 1).
By making use of neuroimaging techniques, new insights into neurobiological mechanisms of eating disorders have been obtained. As with psychological and behavioral eating disorder traits, neurocircuit wiring and their related functioning may also provide novel ways to classify subgroups within the eating disorder population. In a recent review, Kaye et al. (2009) described how altered brain activity in the insula could explain interoceptive dysfunction in anorexia nervosa. Furthermore, altered striatal brain activity may be related to differences in reward signaling in eating disorder patients (Kaye et al. 2009). Behavioral changes seen in the development of anorexia nervosa may be related and maintained by (permanent) brain circuit alterations due to developmental (e.g., puberty) and/or environmental factors (e.g., stressful life events). For those reasons, neuroimaging characteristics may provide a way complementary to behavioral traits to closer study neurobiological circuits underlying eating disorders.
In view of these behavioral and neuro-anatomical characteristics, some considerations should also be taken into account. For instance, some of the core characteristics identified may be highly dependent on each other and/or may reflect the same pathophysiological process. For example, do neurocircuits that underlie disturbed set-shifting in anorexia nervosa (partially) overlap with those of compulsive behavior and/or of perfectionism observed in these patients, or are these truly separate components of the disease? In addition, recent studies have indicated that behavioral hyperactivity seen in anorexia nervosa is related to the levels of anxiety and food restriction (Holtkamp et al. 2004), indicating that some behavioral characteristics are highly dependent on others. This requires practical considerations about study design to assess these potentially related eating disorder characteristics properly. Once we understand better the mechanisms underlying the traits that contribute to the development and maintenance of an eating disorder, new horizons arise for novel treatments. Future research is necessary to study the relation between these eating disorder characteristics, and the genetic pathways and neural circuits underlying the pathophysiological neuroprocesses that drive these behavioral characteristics.
3 Rational for Animal Models of Eating Disorders
Understanding the biology of behavioral disorders, including eating disorders, requires identifying and functionally testing biological substrates in relation to these disorders. Interference with, for example, pharmacological agents or genetic manipulations is a standard tool in animal research to test their involvement in physiological processes. Animal studies allow systematic studies in which environmental and genetic factors can largely be controlled for. The challenge is, of course, how to develop an animal model for eating disorders, such as anorexia nervosa. Indeed, validity of translational animal models is widely accepted for common physiological processes (such as blood pressure regulation); however, cross-species comparison for psychiatric disorders offers a challenging opportunity for biomedical research (Dennis 2005).
Recently, a proof of concept of the confluence between mouse and human for psychiatric traits was presented by Chen (Chen et al. 2006). A common genetic variant of the brain-derived neurotrophic factor (BDNF) gene in humans is associated with alterations in brain anatomy, memory and has been associated with psychiatric disorders, such as eating disorders, depression, and schizophrenia (Egan et al. 2003; Ribases et al. 2004; Lang et al. 2005; Lohoff et al. 2005; Neves-Pereira et al. 2005; Ribases et al. 2005; Schumacher et al. 2005). BDNF has an important function in neuronal survival, differentiation, and synaptic plasticity. Chen and co-workers showed that when the human Val66Met variant is genetically introduced in mice, it exhibits phenotypic characteristics in humans with the variant allele, including anxiety-related behaviors. This finding illustrates the potential of comparative neurobehavioral genetic studies between mouse and human.
Interestingly, certain behavioral domains that are affected in eating disorders may be relevant across the psychiatric spectrum. For example, set-shifting difficulties are observed in anorexia and bulimia nervosa (Tchanturia et al. 2004; Holliday et al. 2005), but are also observed in obsessive–compulsive disorders, suggesting that there may be common neurobiological mechanisms underlying certain aspects across diagnosis. Moreover, certain behavioral domains, such as intra- and extra-dimensional set-shifting can be studied in animals as well (Birrell and Brown 2000; Brigman et al. 2005; Bissonette et al. 2008). These behavioral domains may provide a good starting point for understanding the neurobiological mechanisms underlying these behavioral disorders (Fig. 1).
4 How These Traits Are Mimicked in Animals
As indicated with the Val66Met variant in the BDNF gene, studying gene function in relation to behavioral deficits across species may be one way to go in view of translational research for psychiatric disorders. In addition, novel gene identification methodologies for behavioral traits are another option and have been largely developed. For instance, with the current availability of a large variety of inbred mouse strains and their known genome sequences (Frazer et al. 2007; Yang et al. 2007), mouse genetics offer a challenging way to study complex neurobehavioral traits. In contrast to patient populations, mouse strains can be used to control for phenotypic and genetic heterogeneity as well as for studies aiming at understanding complex gene–environment interactions. With the recent generation of genetic reference populations, such as recombinant inbred strains (RIS) (Plomin et al. 1991) and chromosome substitution strains (CSS) (Singer et al. 2004), quantitative trait loci (QTL) analysis can be performed for complex neurobiological traits in mice. Additional approaches for mice, such as haplotype mapping (Grupe et al. 2001; Wade et al. 2002; Wade and Daly 2005), genome-wide gene expression (Sandberg et al. 2000; Jansen and Nap 2001; Fernandes et al. 2004; Letwin et al. 2006; Hovatta et al. 2007), and quantitative complementation studies (Yalcin et al. 2004) provide a complementary technological platform for gene identification. With the technology in place, the true challenge for this translational approach is the development of appropriate animal models for eating disorders and exposure of genetically defined mice to these models.
The activity-based anorexia (ABA) or semi-starvation-induced hyperactivity model is, among others (Siegfried et al. 2003), a known animal model to study pathophysiological processes in anorexia nervosa. The ABA model is around since the 1960s (Routtenberg and Kuznesof 1967) and ABA is induced in rodents with voluntary access to running wheels and that are exposed to daily scheduled restricted food availability. Reminiscent of anorexia nervosa, certain rat and mouse inbred strains exposed to this daily scheduled feeding paradigm exhibit a paradoxical behavioral hyperactivity with reduced food availability and a subsequent accelerated body weight loss (Kas et al. 2003a; Gelegen et al. 2007). Excessive behavioral hyperactivity may be a core trait of anorexia nervosa (Brewerton et al. 1995b; Bergh and Sodersten 1996; Davis et al. 1997, 1999; Hebebrand et al. 2003). In addition, it has been shown that Olanzapine, an anti-psychotic drug, can suppress behavioral hyperactivity in both anorexia nervosa patients and rodents exposed to the ABA model (Hillebrand et al. 2005b). Furthermore, plasma leptin levels are correlated with physical activity levels in anorexia nervosa patients during the acute phase of the illness (Holtkamp et al. 2003; van Elburg et al. 2007), and chronic leptin infusion suppresses behavioral activity in rats exposed to the ABA model (Exner et al. 2000; Hillebrand et al. 2005a). Moreover, reminiscent of the high incidence of anorexia nervosa in young females (in the age of 15–19 years) (Hoek 2006), young adolescent rodents are more susceptible to ABA than older rodents (Barbarich-Marsteller et al. 2007). Taken together, these findings provide some face- and predictive validity of the model for pathophysiological processes observed in anorexia nervosa.
By screening a panel of CSS in the ABA model, we have recently found that different behavioral characteristics of the model can be genetically dissociated. In a CSS panel, each of the 21 mouse substrains has a C57BL/6J genetic background with a single A/J chromosome being substituted (e.g., CSS 1 carries A/J chromosome 1 in a C57BL/6J genetic background). This allows studying the contribution of single A/J chromosomes to phenotypes and providing a starting point for genetically fine mapping loci on those chromosomes that contribute to the phenotype of interest. When this particular CSS panel was tested in the ABA model, some substrains showed disorganized behavioral hyperactivity with accelerated body weight loss (Gelegen et al. 2010), while other substrains exhibited behavioral hyperactivity during the hours of limited food access (Kas et al. 2010). Some of the substrains did not contribute to ABA phenotypes. Together, these data showed that behavioral components within the ABA model can be dissociated using these CSS and that the dissected components are regulated by mechanisms of different genetic origin. Interestingly, these dissociable ABA phenotypes affect different aspects relevant to the progression and maintenance of eating disorder characteristics. For example, the disorganized behavioral hyperactivity phenotype observed in certain CSS led to accelerated body weight loss (Gelegen et al. 2010), whereas the high levels of running during the daily hours that food is present directly interferes with the eating behavior itself (Kas et al. 2010).
At the genetic level, these findings using CSS may contribute to identify novel mechanisms underlying these eating disorder traits. For example, genomic regions on A/J chromosomes that contributed to disorganized behavioral hyperactivity and subsequent accelerated body way loss display homology with regions on human chromosomes linked with genetic linkage regions in anorexia nervosa cohorts. For example, a region on human chromosome 1 (1p34.2) has been linked to the restricting subtype of AN (characterized by a severe limitation in food intake) (Grice et al. 2002), and this region shows complete overlap with a long region of mouse chromosome 4 that was identified in our genetic screen (Gelegen et al. 2010). For the other dissociable phenotype, behavioral hyperactivity during food access (Kas et al. 2010), the identified mouse chromosomes overlap with two previously observed human OCD chromosomal regions 7p and 15q (Shugart et al. 2006), suggesting that there may be overlap in compulsive wheel running during food access (while being food restricted) and compulsivity in OCD. In this way, our data open new roads for interspecies genetic studies for these neurobehavioral traits that may be relevant to anorexia nervosa and OCD.
In addition to studies that focus on behavioral traits within animal models for eating disorders, such as behavioral hyperactivity in the ABA model, one could also consider modeling susceptibility traits of eating disorders. As described above, anxiety disorders are highly comorbid with eating disorders (Fornari et al. 1999; Godart et al. 2006). Anxiety disorders, such as social phobia, may represent risk factors for eating disorders and could share common mechanisms that are relevant to the development of anorexia and bulimia nervosa. Animal models for these susceptibility traits may reveal new insights into the mechanisms underlying eating disorder development. Table 2 presents a list of characteristics that are relevant to eating disorders and approaches to their measurement in humans together with potential analogous rodent models and their measurement approaches (from Kas et al. 2009).
While animal models cannot mimic all eating disorder traits, such as perfectionism, body dissatisfaction, or drive for thinness, behavioral scientists have been working for decades on animal models for other behavioral characteristics relevant to anorexia and bulimia nervosa, such as, e.g., depressive symptoms [for review, see (Redei et al. 2001; Nestler et al. 2002; Cryan and Mombereau 2004; Cryan and Holmes 2005; Dranovsky and Hen 2006)], for compulsive behavior [for review, see (Joel 2006; Korff and Harvey 2006)], for impulsivity [for review, see (Evenden 1999; Jentsch and Taylor 1999; Lesch and Merschdorf 2000)], for set-shifting (Brigman et al. 2005; Brooks et al. 2006), and for body weight regulation [for review, see (Rohner-Jeanrenaud and Jeanrenaud 1997; Barsh et al. 2000; Mercer and Tups 2003; Adan et al. 2006; Buettner et al. 2007)]. Insights into mechanisms underlying these separate components may contribute to understanding the development of heterogeneity within eating disorder populations. Nevertheless, novel advances to refine assessments of these behavioral components in rodents are needed to optimize animal research for eating disorder traits.
As indicated above, there is substantial comorbidity of eating disorders and anxiety disorders [for review, see (Swinbourne and Touyz 2007)]. Studies have consistently shown that a significant number of patients with anorexia nervosa or bulimia nervosa experience one or more anxiety disorders (Kaye et al. 2004). Lifetime prevalence of at least one anxiety disorder in individuals with eating disorders varies from 25% (Keck et al. 1990) to 75% (Schwalberg et al. 1992) in bulimia nervosa and from 23% (Laessle et al. 1991) to 75% (Deep et al. 1995) in anorexia nervosa. Several studies have shown that anxiety disorders are premorbid to the development of an eating disorder (Schwalberg et al. 1992; Brewerton et al. 1995b; Deep et al. 1995; Bulik 2002; Godart et al. 2003; Brewerton et al. 1995a), indicating that studies unveiling mechanisms underlying anxiety disorders may provide insights into susceptibility factors for eating disorders.
In rodents, considerable information exists on the determination of anxiety levels. Standard laboratory tests, such as the open field, elevated plus maze, and the light–dark box test, are generally used to measure novelty-induced anxiety levels in rodents. In general, rodent species have an innate preference for sheltered places that have lower light intensities than the outside world and that provide a sense of safety via body contact with the shelter area surface (thigmotaxis). The open field test was one of the first behavioral tests developed for emotionality and that was based on the assessment of these behavioral expressions (Hall 1936). These relatively brief tests provide insights in novelty-responsiveness of the animal, but are confounded by strain differences in locomotor activity and do not provide baseline measures of anxiety levels. For these reasons, the field will benefit from novel measures that assess baseline anxiety levels and control for strain differences in locomotor activity (Kas and Van Ree 2004; Kas et al. 2008). By means of interspecies genetic analysis, we have recently found an association at the genetic level between increased baseline sheltering preference (using longitudinal automated home cage observations) and a human mood disorder (de Mooij-van Malsen et al. 2009). Furthermore, in addition to measures of anxiety levels in relation to novel environments with a nonsocial context, animal models for social phobia have also been introduced and may be relevant to eating disorder development. For instance, behavioral tests have been developed in which rodents can be tested for their preference for social approach or avoidance (Nadler et al. 2004; Moy et al. 2007). These refinements in rodent behavioral testing paradigms will contribute to face, predictive, and construct validity of animal models for eating disorder traits.
In addition to the development of behavioral testing paradigms to assess eating disorder characteristics in both mouse and human, neuroimaging approaches have recently been initiated across species to picture brain activities in relation to eating disorder development. For example, a recent study (Wagner et al. 2007) showed that individuals who have recovered from restricting-type anorexia nervosa had altered patterns of response in the ventral and dorsal striatum to positive and negative feedback. That is, an anterior ventral striatum response that distinguished between winning and losing was seen in the comparison women but not in the anorexia nervosa group. These findings suggest that individuals with anorexia nervosa may have difficulty discriminating between positive and negative feedback, relative to healthy comparison subjects. Similarly, in a study using a startle reflex paradigm (Friederich et al. 2006), a generalized failure to activate the appetitive motivational system was observed in individuals with anorexia nervosa. Interestingly, Barbarich-Marsteller et al. (2005) found changes in the striatum, hippocampus, and thalamus in rodents exposed to the ABA model. Similarly, van Kuyck et al. (2007) found altered activity in the ventral striatum, insula, thalamus, and ventral pontine nuclei, as well as a positive correlation between body weight loss and metabolism in the anterior cingulate and related regions in ABA rodents. When considered together, these human and rodent studies suggest the possibility of involvement of common pathways, but differences in imaging techniques and the effects of nutritional status make direct comparisons problematic.
Integration of genetic, behavioral, and neuroimaging findings may, in the end, provide more complete insight into the mechanisms underlying complex disorders. For example, increased anterior ventral striatum dopamine D2/D3 receptor binding in recovered anorexia nervosa patients could be contributing to the above-mentioned alteration in anterior ventral striatum function (Frank et al. 2005). Disturbed dopamine D2 receptor binding observed by these brain imaging techniques would be consistent with recently observed genetic linkage with the dopamine D2 receptor and anorexia nervosa (Nisoli et al. 2007; Bergen et al. 2005). Furthermore, recent animal studies have shown that mice with high susceptibility to develop ABA have increased striatal dopamine D2 receptor mRNA levels when compared to mice that do not develop behavioral hyperactivity in this animal model (Gelegen et al. 2008). In view of the relation between dopamine D2 receptor regulation and eating disorders and reward seeking in humans (Blum et al. 1995), it is interesting to note that mice with a genetic deletion of this receptor have deficits in reward processes (Maldonado et al. 1997; Cunningham et al. 2000; Elmer et al. 2002; Tran et al. 2002; Drew et al. 2007) that may also translate to certain aspects observed in eating disorders (Bergh and Sodersten 1996).
5 Future Directions
Eating disorders are multifactorial psychiatric disorders with unknown etiology and (at this point) relatively low success rate with current treatment programs. Understanding the complex interactions of genetic background and environmental factors will become crucial in unraveling the biology of this disease. More and more, the role of the environment, gender, and critical time periods during development have raised awareness in the development of this disease. Hand-in-hand with upcoming genetic findings, systematic and controlled animal studies will, therefore, play an important role to study their relationship in the development of eating disorders.
Extensive human genetic studies are underway and will provide novel candidate genes for eating disorders, such as anorexia nervosa. To unravel the contribution of these candidate genes in a neurobiological mechanism underlying eating disorders, translational research will be needed. Gene knockout technology in mice has provided a tremendous contribution to gene function research in all biomedical disciplines. This has evolved in novel and refined applications, such as conditional knockout technology, vector-directed gene expression, and short-hairpin interference methodologies to study gene function relationships over time [e.g., genetic deletion during development or adulthood (Gross et al. 2002) and in a tissue-specific manner]. Thus, sufficient gene manipulation technology is available to functionally test human candidate genes for anorexia nervosa. Furthermore, novel mouse genetic mapping panels allow the identification of genomic regions for mouse phenotypes that are homologous with human genomic regions identified for eating disorder characteristics (Gelegen et al. 2010; Kas et al. 2010). Together, in combination with relevant animal paradigms at the behavioral and neuro-anatomical level for eating disorder traits, these methods will contribute to unravel gene functions in neurobiological mechanisms underlying the pathophysiology of self-starvation. Better understanding of the pathophysiology of eating disorders will pave new roads for directed treatment development.
References
Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, de Krom M (2006) The MC4 receptor and control of appetite. Br J Pharmacol 149:815–827
Barbarich-Marsteller NC, Marsteller DA, Alexoff DL, Fowler JS, Dewey SL (2005) MicroPET imaging in an animal model of anorexia nervosa. Synapse 57:85–90
Barbarich-Marsteller N, Pike K, Underwood M, Foltin R, Walsh B (2007) Vulnerability of activity-based anorexia in adolescent female rats. Abstr Annu Meet Eat Disord Res Soc P8
Barsh GS, Farooqi IS, O'rahilly S (2000) Genetics of body-weight regulation. Nature 404:644–651
Bergen AW, Yeager M, Welch RA, Haque K, Ganjei JK, van den Bree MB, Mazzanti C, Nardi I, Fichter MM, Halmi KA, Kaplan AS, Strober M, Treasure J, Woodside DB, Bulik CM, Bacanu SA, Devlin B, Berrettini WH, Goldman D, Kaye WH (2005) Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology 30:1703–1710
Bergh C, Sodersten P (1996) Anorexia nervosa, self-starvation and the reward of stress. Nat Med 2:21–22
Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320–4324
Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM (2008) Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 28:11124–11130
Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE (1995) Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 5:121–141
Brewerton TD, Lydiard RB, Herzog DB, Brotman AW, O'Neil PM, Ballenger JC (1995a) Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry 56:77–80
Brewerton TD, Stellefson EJ, Hibbs N, Hodges EL, Cochrane CE (1995b) Comparison of eating disorder patients with and without compulsive exercising. Int J Eat Disord 17:413–416
Brigman JL, Bussey TJ, Saksida LM, Rothblat LA (2005) Discrimination of multidimensional visual stimuli by mice: intra- and extradimensional shifts. Behav Neurosci 119:839–842
Brooks SP, Betteridge H, Trueman RC, Jones L, Dunnett SB (2006) Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease. Brain Res Bull 69:452–457
Buettner R, Scholmerich J, Bollheimer LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15:798–808
Bulik CM (2002) Eating disorders in adolescents and young adults. Child Adolesc Psychiatr Clin N Am 11:201–218
Bulik CM, Sullivan PF, Fear JL, Joyce PR (1997) Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr Scand 96:101–107
Bulik CM, Hebebrand J, Keski-Rahkonen A, Klump KL, Reichborn-Kjennerud T, Mazzeo SE, Wade TD (2007a) Genetic epidemiology, endophenotypes, and eating disorder classification. Int J Eat Disord 40(Suppl):S52–S60
Bulik CM, Slof-Op't Landt MC, van Furth EF, Sullivan PF (2007b) The genetics of anorexia nervosa. Annu Rev Nutr 27:263–275
Carter FA, McIntosh VV, Joyce PR, Gendall KA, Frampton CM, Bulik CM (2004) Patterns of weight change after treatment for bulimia nervosa. Int J Eat Disord 36:12–21
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140–143
Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775–790
Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9:326–357
Cunningham CL, Howard MA, Gill SJ, Rubinstein M, Low MJ, Grandy DK (2000) Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. Pharmacol Biochem Behav 67:693–699
Davis C, Katzman DK, Kaptein S, Kirsh C, Brewer H, Kalmbach K, Olmsted MP, Woodside DB, Kaplan AS (1997) The prevalence of high-level exercise in the eating disorders: etiological implications. Compr Psychiatry 38:321–326
Davis C, Katzman DK, Kirsh C (1999) Compulsive physical activity in adolescents with anorexia nervosa: a psychobehavioral spiral of pathology. J Nerv Ment Dis 187:336–342
de Mooij-van Malsen AJ, van Lith HA, Oppelaar H, Hendriks J, de Wit M, Kostrzewa E, Breen G, Collier DA, Olivier B, Kas MJ (2009) Interspecies trait genetics reveals association of Adcy8 with mouse avoidance behavior and a human mood disorder. Biol Psychiatry 66:1123–1130
Deep AL, Nagy LM, Weltzin TE, Rao R, Kaye WH (1995) Premorbid onset of psychopathology in long-term recovered anorexia nervosa. Int J Eat Disord 17:291–297
Dennis C (2005) Psychiatric disease: all in the mind of a mouse. Nature 438:151–152
Dranovsky A, Hen R (2006) Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59:1136–1143
Drew MR, Simpson EH, Kellendonk C, Herzberg WG, Lipatova O, Fairhurst S, Kandel ER, Malapani C, Balsam PD (2007) Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci 27:7731–7739
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269
Elmer GI, Pieper JO, Rubinstein M, Low MJ, Grandy DK, Wise RA (2002) Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 22:RC224
Evenden J (1999) Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13:180–192
Exner C, Hebebrand J, Remschmidt H, Wewetzer C, Ziegler A, Herpertz S, Schweiger U, Blum WF, Preibisch G, Heldmaier G, Klingenspor M (2000) Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa. Mol Psychiatry 5:476–481
Fairburn CG, Harrison PJ (2003) Eating disorders. Lancet 361:407–416
Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, Schalkwyk LC (2004) Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci 19:2576–2582
Fornari V, Wlodarczyk-Bisaga K, Matthews M, Sandberg D, Mandel FS, Katz JL (1999) Perception of family functioning and depressive symptomatology in individuals with anorexia nervosa or bulimia nervosa. Compr Psychiatry 40:434–441
Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, Mathis CA, Wagner A, Hoge J, Ziolko S, Barbarich-Marsteller N, Weissfeld L, Kaye WH (2005) Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry 58:908–912
Frazer KA, Eskin E, Kang HM, Bogue MA, Hinds DA, Beilharz EJ, Gupta RV, Montgomery J, Morenzoni MM, Nilsen GB, Pethiyagoda CL, Stuve LL, Johnson FM, Daly MJ, Wade CM, Cox DR (2007) A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 448:1050–1053
Friederich HC, Kumari V, Uher R, Riga M, Schmidt U, Campbell IC, Herzog W, Treasure J (2006) Differential motivational responses to food and pleasurable cues in anorexia and bulimia nervosa: a startle reflex paradigm. Psychol Med 36:1327–1335
Gelegen C, Collier DA, Campbell IC, Oppelaar H, van den HJ A, RA KMJ (2007) Difference in susceptibility to activity-based anorexia in two inbred strains of mice. Eur Neuropsychopharmacol 17:199–205
Gelegen C, van den Heuvel J, Collier DA, Campbell IC, Oppelaar H, Hessel E, Kas MJ (2008) Dopaminergic and BDNF signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav 7:552–559
Gelegen C, Pjetri E, Campbell IC, Collier DA, Oppelaar H, Kas MJ (2010) Chromosomal mapping of excessive physical activity in mice in response to a restricted feeding schedule. Eur Neuropsychopharmacol 20(5): 317–326
Godart NT, Flament MF, Perdereau F, Jeammet P (2002) Comorbidity between eating disorders and anxiety disorders: a review. Int J Eat Disord 32:253–270
Godart NT, Flament MF, Curt F, Perdereau F, Lang F, Venisse JL, Halfon O, Bizouard P, Loas G, Corcos M, Jeammet P, Fermanian J (2003) Anxiety disorders in subjects seeking treatment for eating disorders: a DSM-IV controlled study. Psychiatry Res 117:245–258
Godart N, Berthoz S, Perdereau F, Jeammet P (2006) Comorbidity of anxiety with eating disorders and OCD. Am J Psychiatry 163:326–329
Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645
Grice DE, Halmi KA, Fichter MM, Strober M, Woodside DB, Treasure JT, Kaplan AS, Magistretti PJ, Goldman D, Bulik CM, Kaye WH, Berrettini WH (2002) Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet 70:787–792
Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396–400
Grupe A, Germer S, Usuka J, Aud D, Belknap JK, Klein RF, Ahluwalia MK, Higuchi R, Peltz G (2001) In silico mapping of complex disease-related traits in mice. Science 292:1915–1918
Hall CS (1936) Emotional behavior in the rat. III The relationship between emotionality and ambulatory activity. J Comp Psychol 22:345–352
Halmi KA, Sunday SR, Klump KL, Strober M, Leckman JF, Fichter M, Kaplan A, Woodside B, Treasure J, Berrettini WH, Al Shabboat M, Bulik CM, Kaye WH (2003) Obsessions and compulsions in anorexia nervosa subtypes. Int J Eat Disord 33:308–319
Hebebrand J, Exner C, Hebebrand K, Holtkamp C, Casper RC, Remschmidt H, Herpertz-Dahlmann B, Klingenspor M (2003) Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav 79:25–37
Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT, Greenwood DN, Burwell RA, Keller MB (1999) Recovery and relapse in anorexia and bulimia nervosa: a 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry 38:829–837
Hillebrand JJ, Koeners MP, de Rijke CE, Kas MJ, Adan RA (2005a) Leptin treatment in activity-based anorexia. Biol Psychiatry 58:165–171
Hillebrand JJ, van Elburg AA, Kas MJ, van Engeland H, Adan RA (2005b) Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa? Biol Psychiatry 58:651–657
Hinney A, Remschmidt H, Hebebrand J (2000) Candidate gene polymorphisms in eating disorders. Eur J Pharmacol 410:147–159
Hoek HW (2006) Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 19:389–394
Holliday J, Tchanturia K, Landau S, Collier D, Treasure J (2005) Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry 162:2269–2275
Holtkamp K, Herpertz-Dahlmann B, Mika C, Heer M, Heussen N, Fichter M, Herpertz S, Senf W, Blum WF, Schweiger U, Warnke A, Ballauff A, Remschmidt H, Hebebrand J (2003) Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab 88:5169–5174
Holtkamp K, Hebebrand J, Herpertz-Dahlmann B (2004) The contribution of anxiety and food restriction on physical activity levels in acute anorexia nervosa. Int J Eat Disord 36:163–171
Hovatta I, Zapala MA, Broide RS, Schadt EE, Libiger O, Schork NJ, Lockhart DJ, Barlow C (2007) DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: implications for eQTL mapping studies. Genome Biol 8:R25
Jansen RC, Nap JP (2001) Genetical genomics: the added value from segregation. Trends Genet 17:388–391
Jentsch JD, Taylor JR (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146:373–390
Joel D (2006) Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry 30:374–388
Kas MJ, Van Ree JM (2004) Dissecting complex behaviours in the post-genomic era. Trends Neurosci 27:366–369
Kas MJ, van Dijk G, Scheurink AJ, Adan RA (2003a) Agouti-related protein prevents self-starvation. Mol Psychiatry 8:235–240
Kas MJ, van Elburg AA, van Engeland H, Adan RA (2003b) Refinement of behavioural traits in animals for the genetic dissection of eating disorders. Eur J Pharmacol 480:13–20
Kas MJ, Fernandes C, Schalkwyk LC, Collier DA (2007) Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men. Mol Psychiatry 12:324–330
Kas MJ, de Mooij-van Malsen JG, Olivier B, Spruijt BM, Van Ree JM (2008) Differential genetic regulation of motor activity and anxiety-related behaviors in mice using an automated home cage task. Behav Neurosci 122(4):769–76
Kas MJ, Kaye WH, Foulds MW, Bulik CM (2009) Interspecies genetics of eating disorder traits. Am J Med Genet B Neuropsychiatr Genet 150B:318–327
Kas MJ, Gelegen C, van Nieuwerburgh F, Westenberg HG, Deforce D, Denys D (2010) Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 153B:252–259
Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K (2004) Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 161:2215–2221
Kaye WH, Fudge JL, Paulus M (2009) New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 10:573–584
Keck P, Pope H, Hudson JL, McElroy S, Yurgelung-Todd D, Hundert E (1990) A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry 31:275–283
Keski-Rahkonen A, Neale BM, Bulik CM, Pietilainen KH, Rose RJ, Kaprio J, Rissanen A (2005) Intentional weight loss in young adults: sex-specific genetic and environmental effects. Obes Res 13:745–753
Klump KL, Gobrogge KL (2005) A review and primer of molecular genetic studies of anorexia nervosa. Int J Eat Disord 37(Suppl):S43–S48
Korff S, Harvey BH (2006) Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Psychiatr Clin North Am 29:371–390
Laessle RG, Beumont PJ, Butow P, Lennerts W, O'Connor M, Pirke KM, Touyz SW, Waadt S (1991) A comparison of nutritional management with stress management in the treatment of bulimia nervosa. Br J Psychiatry 159:250–261
Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J (2005) Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180:95–99
Lesch KP, Merschdorf U (2000) Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 18:581–604
Letwin NE, Kafkafi N, Benjamini Y, Mayo C, Frank BC, Luu T, Lee NH, Elmer GI (2006) Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene-behavior associations. J Neurosci 26:5277–5287
Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH (2005) Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 139:51–53
Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388:586–589
Mazzeo SE, Slof-Op't Landt MC, Jones I, Mitchell K, Kendler KS, Neale MC, Aggen SH, Bulik CM (2006) Associations among postpartum depression, eating disorders, and perfectionism in a population-based sample of adult women. Int J Eat Disord 39:202–211
Mazzeo SE, Mitchell KS, Bulik CM, Reichborn-Kjennerud T, Kendler KS, Neale MC (2009) Assessing the heritability of anorexia nervosa symptoms using a marginal maximal likelihood approach. Psychol Med 39:463–473
Mercer JG, Tups A (2003) Neuropeptides and anticipatory changes in behaviour and physiology: seasonal body weight regulation in the Siberian hamster. Eur J Pharmacol 480:43–50
Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN (2007) Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 176:4–20
Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN (2004) Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3:303–314
Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, Hen R, Koester S, Lederhendler I, Meaney M, Robbins T, Winsky L, Zalcman S (2002) Preclinical models: status of basic research in depression. Biol Psychiatry 52:503–528
Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM (2005) BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10:208–212
Nisoli E, Brunani A, Borgomainerio E, Tonello C, Dioni L, Briscini L, Redaelli G, Molinari E, Cavagnini F, Carruba MO (2007) D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12:91–96
Plomin R, McClearn GE, Gora-Maslak G, Neiderhiser JM (1991) Use of recombinant inbred strains to detect quantitative trait loci associated with behavior. Behav Genet 21:99–116
Redei EE, Ahmadiyeh N, Baum AE, Sasso DA, Slone JL, Solberg LC, Will CC, Volenec A (2001) Novel animal models of affective disorders. Semin Clin Neuropsychiatry 6:43–67
Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M, Cavallini MC, Cellini E, Di Bella D, Erzegovesi S, Foulon C, Gabrovsek M, Gorwood P, Hebebrand J, Hinney A, Holliday J, Hu X, Karwautz A, Kipman A, Komel R, Nacmias B, Remschmidt H, Ricca V, Sorbi S, Wagner G, Treasure J, Collier DA, Estivill X (2004) Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet 13:1205–1212
Ribases M, Gratacos M, Fernandez-Aranda F, Bellodi L, Boni C, Anderluh M, Cristina CM, Cellini E, Di Bella D, Erzegovesi S, Foulon C, Gabrovsek M, Gorwood P, Hebebrand J, Hinney A, Holliday J, Hu X, Karwautz A, Kipman A, Komel R, Nacmias B, Remschmidt H, Ricca V, Sorbi S, Tomori M, Wagner G, Treasure J, Collier DA, Estivill X (2005) Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet 13:428–434
Rohner-Jeanrenaud E, Jeanrenaud B (1997) Central nervous system and body weight regulation. Ann Endocrinol (Paris) 58:137–142
Routtenberg A, Kuznesof AW (1967) Self-starvation of rats living in activity wheels on a restricted feeding schedule. J Comp Physiol Psychol 64:414–421
Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C (2000) Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 97:11038–11043
Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmal C, Hofels S, Zobel A, Illig T, Propping P, Holsboer F, Rietschel M, Nothen MM, Cichon S (2005) Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58:307–314
Schwalberg MD, Barlow DH, Alger SA, Howard LJ (1992) Comparison of bulimics, obese binge eaters, social phobics, and individuals with panic disorder on comorbidity across DSM-III-R anxiety disorders. J Abnorm Psychol 101:675–681
Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G (2006) Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11:763–770
Siegfried Z, Berry EM, Hao S, Avraham Y (2003) Animal models in the investigation of anorexia. Physiol Behav 79:39–45
Singer JB, Hill AE, Burrage LC, Olszens KR, Song J, Justice M, O'Brien WE, Conti DV, Witte JS, Lander ES, Nadeau JH (2004) Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304:445–448
Swinbourne JM, Touyz SW (2007) The co-morbidity of eating disorders and anxiety disorders: a review. Eur Eat Disord Rev 15:253–274
Tchanturia K, Morris RG, Anderluh MB, Collier DA, Nikolaou V, Treasure J (2004) Set shifting in anorexia nervosa: an examination before and after weight gain, in full recovery and relationship to childhood and adult OCPD traits. J Psychiatr Res 38:545–552
Toner BB, Garfinkel PE, Garner DM (1988) Affective and anxiety disorders in the long-term follow-up of anorexia nervosa. Int J Psychiatry Med 18:357–364
Tran AH, Tamura R, Uwano T, Kobayashi T, Katsuki M, Matsumoto G, Ono T (2002) Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice. Proc Natl Acad Sci USA 99:8986–8991
Treasure J, Claudino AM, Zucker N (2010) Eating disorders. Lancet 375(9714):583–593
van Elburg AA, Kas MJ, Hillebrand JJ, Eijkemans RJ, van Engeland H (2007) The impact of hyperactivity and leptin on recovery from anorexia nervosa. J Neural Transm 114:1233–1237
van Kuyck K, Casteels C, Vermaelen P, Bormans G, Nuttin B, Van Laere K (2007) Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: a voxel-based microPET study. Neuroimage 35:214–221
Wade CM, Daly MJ (2005) Genetic variation in laboratory mice. Nat Genet 37:1175–1180
Wade CM, Kulbokas EJ III, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, Daly MJ (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420:574–578
Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazurkewicz L, Frank GK, Bailer UF, Fischer L, Nguyen V, Carter C, Putnam K, Kaye WH (2007) Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry 164:1842–1849
Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, Deacon RM, Rawlins JN, Copley RR, Morris AP, Flint J, Mott R (2004) Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet 36:1197–1202
Yang H, Bell TA, Churchill GA, Pardo-Manuel dV (2007) On the subspecific origin of the laboratory mouse. Nat Genet 39:1100–1107
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kas, M.J.H., Adan, R.A.H. (2010). Animal Models of Eating Disorder Traits. In: Adan, R., Kaye, W. (eds) Behavioral Neurobiology of Eating Disorders. Current Topics in Behavioral Neurosciences, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2010_84
Download citation
DOI: https://doi.org/10.1007/7854_2010_84
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-15130-9
Online ISBN: 978-3-642-15131-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)